UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 7, 2021
Accession Number: 0001213900-21-030443
Submission Type: POS AM
CIK: 0001023549
Company Name: XTL BIOPHARMACEUTICALS LTD
File Number: 333-208817